Successful treatment of hepatocellular carcinoma with lung metastasis using hepatic and bronchial artery infusion chemotherapy

Internal Medicine

Volumn 53, Issue 21, 2014, Pages 2493-2497

  Yoshida, Tatsuki ^a   Kamada, Kentaro ^a   Miura, Kouichi ^a   Goto, Takashi ^a   Ohshima, Shigetoshi ^a   Sato, Wataru ^a   Shibuya, Tomomi ^a   Dohmen, Takahiro ^a   Kanata, Ryo ^a   Sakai, Toshitaka ^a   Chiba, Mitsuru ^a   Fujiwara, Junichi ^a   Sugimoto, Yuko ^a   Ishioka, Mitsuaki ^a   Hasegawa, Itsuki ^a   Takahashi, Kenichi ^a   Minami, Shinichiro ^a   Fujita, Akashi ^a   Hashimoto, Manabu ^a   Ohnishi, Hirohide ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchial arterial infusion chemotherapy; Hepatic arterial infusion chemotherapy; Hepatocellular carcinoma; Lung metastasis; Second line chemotherapy

Indexed keywords

ALPHA FETOPROTEIN; CHLOROTRIANISENE; CISPLATIN; DECARBOXYPROTHROMBIN; EPIRUBICIN; IODINATED POPPYSEED OIL; PEGINTERFERON; RIBAVIRIN; SORAFENIB; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HEPATITIS C; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; LUNG METASTASIS; MALE; MIDDLE AGED; MILD HEPATIC IMPAIRMENT; TUMOR THROMBUS; BRONCHIAL ARTERY; CARCINOMA, HEPATOCELLULAR; HEPATIC ARTERY; INTRAARTERIAL DRUG ADMINISTRATION; LIVER NEOPLASMS; LUNG NEOPLASMS; PATHOLOGY; PROCEDURES; SECONDARY;

ANTINEOPLASTIC AGENTS; BRONCHIAL ARTERIES; CARCINOMA, HEPATOCELLULAR; CISPLATIN; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 84908374734     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.2957     Document Type: Article

References (31)

1. Kim DY, Han KH. Epidemiology and surveillance of hepatocellular carcinoma. Liver Cancer 1: 2-14, 2012.
2. Huang GT, Lee PH, Tsang YM, et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 242: 36-42, 2005.
3. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243: 321-328, 2006.
4. Hasegawa K, Kokudo N, Makuuchi M, et al. Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol 58: 724-729, 2013.
5. Takayasu K, Arii S, Ikai I, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131: 461-469, 2006.
6. Uka K, Aikata H, Takaki S, et al. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol 21: 414-420, 2007.
7. Natsuizaka M, Omura T, Akaike T, et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol 20: 1781-1787, 2005.
8. Kudo M, Izumi N, Kokudo N, et al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 29: 339-364, 2011.
9. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 53: 1020-1022, 2011.
10. Kawaoka T, Aikata H, Kan H, et al. Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib. Hepatol Res (in press).
11. Nouso K, Miyahara K, Uchida D, et al. Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan. Br J Cancer 109: 1904-1907, 2013.
12. Ando E, Tanaka M, Yamashita F, et al. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer 95: 588-595, 2002.
13. Terashima T, Yamashita T, Arai K, et al. Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib. Hepatol Res (in press).
14. Jeong SW, Jang JY, Lee JE, et al. The efficacy of hepatic arterial infusion chemotherapy as an alternative to sorafenib in advanced hepatocellular carcinoma. Asia Pac J Clin Oncol 8: 164-171, 2012.
15. Kudo M. Treatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapy. Liver Cancer 1: 62-70, 2012.
16. Nagahama H, Okada S, Okusaka T, et al. Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma. Jpn J Clin Oncol 27: 321-324, 1997.
17. Yoshikawa M, Ono N, Yodono H, Ichida T, Nakamura H. Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma. Hepatol Res 38: 474-483, 2008.
18. Iwasa S, Ikeda M, Okusaka T, et al. Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization. Jpn J Clin Oncol 41: 770-775, 2011.
19. Soderberg CH Jr, Colbert MP, Leone LA. Bronchial artery infusion therapy of lung neoplasms with nitrogen mustard. Surgery 56: 897-904, 1964.
20. Neyazaki T, Ikeda M, Seki Y, Egawa N, Suzuki C. Bronchial artery infusion therapy for lung cancer. Cancer 24: 912-922, 1969.
21. Koshiishi H, Yoshimura T, Okamura T, et al. Evaluation of bronchial arterial infusion (BAI) for metastatic lung tumor from colorectal cancer. Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 31: 1838-1841, 2004 (in Japanese, Abstract in English).
22. Yonezawa M, Seki A, Numoto A, Kawada K, Eguchi K, Kudo T. Successful treatment of metastatic pulmonary tumors by bronchial arterial infusion chemotherapy in two patients with locally well controlled uterine cancer. Acta Med Okayama 48: 109-112, 1994.
23. Komada H, Yamamura M, Kawaguchi Y, et al. Disappearance of lung metastases from hepatocellular carcinoma following bronchial arterial infusion of CDDP and MMC. Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 19 (10 Suppl): 1504-1507, 1992 (in Japanese, Abstract in English).
24. Kawasaki H, Araki K, Hamada S, et al. A case of long survival of hepatocellular carcinoma with lung metastases after right trisegmentectomy due to multi-disciplinary treatment. Shoukaki Geka (Gastroenterological Surgery) 16: 1603-1610, 1993 (in Japanese).
25. Uetsuji S, Yamada O, Komada H, et al. Disappearance of lung metastases from hepatocellular carcinoma after bronchial arterial infusion of epirubicin. Gan No Rinshou (Jpn J Cancer Clin) 42: 181-184, 1996 (in Japanese, Abstract in English).
26. Kogure T, Iwasaki T, Ueno Y, et al. Complete remission of a case of hepatocellular carcinoma with tumor invasion in inferior vena cava and with pulmonary metastasis successfully treated with repeated arterial infusion chemotherapy. Hepatogastroenterology 54: 2113-2116, 2007.
27. Sakamoto H, Amikura K, Tanaka Y, et al. Successful treatment of multiple pulmonary and peritoneal recurrence of hepatocellular carcinoma with bronchial artery infusion therapy and PEIT followed by surgery: a case report. Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 37: 2687-2689, 2010 (in Japanese, Abstract in English).
28. Koyama J, Morizono R, Goto T, et al. A therapeutic effective case of bronchial arterial infusion of fine-powder cisplatin (IA-call) for pulmonary metastases originated from hepatocellular carcinoma. Kanzo (Liver) 54: 19-26, 2013 (in Japanese, Abstract in English).
29. Osaki T, Hanagiri T, Nakanishi R, Yoshino I, Taga S, Yasumoto K. Bronchial arterial infusion is an effective therapeutic modality for centrally located early-stage lung cancer: results of a pilot study. Chest 115: 1424-1428, 1999.
30. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359: 378-390, 2008.
31. Rimassa L, Personeni N, Simonelli M, Santoro A. Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma. Future Oncol 9: 153-165, 2013.